Related Experiment Video
Updated: Aug 5, 2025

12:40
Using Human Induced Pluripotent Stem Cell-derived Hepatocyte-like Cells for Drug Discovery
Published on: May 19, 2018
10.3K
hiPSC-Derived Cells as Models for Drug Discovery 2.0
Rivka Ofir1,2
1The Regenerative Medicine and Stem Cell (RMSC) Research Center, Ben-Gurion University of the Negev, Beer Sheva 84105, Israel.
International Journal of Molecular Sciences
|March 29, 2023
Summary
Human-induced pluripotent stem cells (hiPSCs) offer a renewable method for investigating disease origins and progression. These cells are crucial for understanding the molecular mechanisms underlying various conditions.
Area of Science:
- Biomedical Research
- Stem Cell Biology
- Disease Modeling
Background:
- Human-induced pluripotent stem cells (hiPSCs) provide a unique in vitro model for studying complex biological processes.
- Investigating the molecular underpinnings of disease initiation and deterioration is essential for therapeutic development.
- Sustainable cell sources are critical for advancing regenerative medicine and personalized treatments.
Discussion:
- hiPSCs enable the exploration of disease-specific molecular pathways in a controlled environment.
- Understanding cellular mechanisms of disease progression can reveal novel therapeutic targets.
- The use of hiPSCs facilitates research into the fundamental aspects of human development and disease.
Key Insights:
- hiPSCs are a valuable tool for dissecting the molecular basis of disease.
- This research highlights the potential of hiPSCs in understanding disease initiation and progression.
- The study underscores the importance of hiPSCs in biomedical research.
Outlook:
- Future research can leverage hiPSCs for drug screening and personalized medicine approaches.
- Further investigation into hiPSC differentiation and function will enhance disease modeling capabilities.
- Advancements in hiPSC technology promise to accelerate the discovery of disease treatments.
More Related Videos
Related Concept Videos
EPS and iPS Cells in Disease Research
2.8K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
2.8K
iPS Cell Differentiation
2.8K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.8K
Induced Pluripotent Stem Cells
24.3K
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
24.3K

